Preferences for Tapering Biologic Disease‐Modifying Antirheumatic Drugs Among People With Rheumatoid Arthritis: A Discrete Choice Experiment
For individuals with RA, making decisions about tapering bDMARDs involves considering several factors, with the most important determinants identified as dosing frequency and the risk of disease flare. Understanding patient perspectives of bDMARD tapering may enable physicians to make patient-focused shared health care decisions.
Authors
- Gareth J. Treharne (ORCID: https://orcid.org/0000-0002-0065-2995)
- Suz Jack Chan (ORCID: https://orcid.org/0000-0003-3490-9987)
- Rebecca Grainger (ORCID: https://orcid.org/0000-0001-9201-8678)
- Simon Stebbings (ORCID: https://orcid.org/0000-0002-2824-4440)
- Lisa K. Stamp (ORCID: https://orcid.org/0000-0003-0138-2912)
- Carlo A. Marra (ORCID: https://orcid.org/0000-0002-2625-2121)
- Nicola Dalbeth (ORCID: https://orcid.org/0000-0003-4632-4476)
- Janet M. Y. Cheung (ORCID: https://orcid.org/0000-0001-6341-5594)
Institutions
- The University of Sydney (AU)
- University of Auckland (NZ)
- Curtin University (AU)
- University of Otago (NZ)
Publication Details
- Journal
- Arthritis Care & Research
- Published
- 2024-09-23
- DOI
- https://doi.org/10.1002/acr.25437
- Citations
- 1
- Primary Topic
- Patient-Provider Communication in Healthcare
- Type
- article
- Field-Weighted Citation Impact
- 0.85
Funders
- University of Otago
- University of Aberdeen